ANDA 76314, held by Natco. Topiramate.
As of Nov 15, 2026, ANDA 76314 (Topiramate), held by Natco, was first approved by FDA on Mar 27, 2009, with 12 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 27, 2009 | Original application | Approved |
| Topiramate25MG · tablet;oral | Topiramate | Discontinued |
| Topiramate50MG · tablet;oral | Topiramate | Discontinued |
| Topiramate100MG · tablet;oral | Topiramate | Discontinued |
| Topiramate200MG · tablet;oral | Topiramate | Discontinued |
| Jan 27, 2026 | Supplement 19Labeling · Standard review | Approved | None posted |
| Jan 4, 2024 | Supplement 15Labeling · Standard review | Approved | None posted |
| Jan 4, 2024 | Supplement 17Labeling · Standard review | Approved | None posted |
| Jan 4, 2024 | Supplement 18Labeling · Standard review | Approved | None posted |
| Dec 15, 2015 | Supplement 12Labeling · Standard review | Approved | None posted |
| Dec 15, 2015 | Supplement 13Labeling · Standard review | Approved | None posted |
| Dec 15, 2015 | Supplement 14Labeling · Standard review | Approved | None posted |
| Oct 22, 2014 | Supplement 10Labeling · Standard review | Approved | None posted |
| Oct 22, 2014 | Supplement 11Labeling · Standard review | Approved | None posted |
| Jul 15, 2011 | Supplement 9Labeling | Approved | None posted |
| Oct 30, 2010 | Supplement 3Labeling | Approved | None posted |
| Jan 13, 2010 | Supplement 1Labeling | Approved | None posted |
| Mar 27, 2009 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters